Literature DB >> 19658096

Multiple functions of human T cells generated by experimental malaria challenge.

Stephen M Todryk1, Michael Walther, Philip Bejon, Claire Hutchings, Fiona M Thompson, Britta C Urban, David W Porter, Adrian V S Hill.   

Abstract

Protective immunity generated following malaria infection may be comprised of Ab or T cells against malaria Ag of different stages; however, the short-lived immunity that is observed suggests deficiency in immune memory or regulatory activity. In this study, cellular immune responses were investigated in individuals receiving Plasmodium falciparum sporozoite challenge by the natural (mosquito bite) route as part of a malaria vaccine efficacy trial. Parasitemia, monitored by blood film microscopy and PCR, was subsequently cleared with drugs. All individuals demonstrated stable IFN-gamma, IL-2 and IL-4 ex vivo ELISPOT effector responses against P. falciparum-infected RBC (iRBC) Ag, 28 and 90 days after challenge. However, infected RBC-specific central memory responses, as measured by IFN-gamma cultured ELISPOT, were low and unstable over time, despite CD4(+) T cells being highly proliferative by CFSE dilution, and showed an inverse relationship to parasite density. In support of the observation of poor memory, co-culture experiments showed reduced responses to common recall Ag, indicating malaria-specific regulatory activity. This activity could not be accounted for by the expression of IL-10, TGF-beta, FOXP3 or CTLA-4, but proliferating T cells expressed high levels of CD95, indicating a pro-apoptotic phenotype. Lastly, there was an inverse relationship between FOXP3 expression, when measured 10 days after challenge, and ex vivo IFN-gamma measured more than 100 days later. This study shows that malaria infection elicits specific Th1 and Th2 effector cells, but concomitant weak central memory and regulatory activity, which may help to explain the short-lived immunity observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19658096     DOI: 10.1002/eji.200939434

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria.

Authors:  Tiffany Sun; Thomas Holowka; Yan Song; Swen Zierow; Lin Leng; Yibang Chen; Huabao Xiong; Jason Griffith; Mehdi Nouraie; Philip E Thuma; Elias Lolis; Chris J Janse; Victor R Gordeuk; Kevin Augustijn; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  An adjuvant-modulated vaccine response in human whole blood.

Authors:  Jalil Hakimi; Ali Azizi; Salvador F Ausar; Stephen M Todryk; Nausheen Rahman; Roger H Brookes
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 3.  Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Authors:  Danielle I Stanisic; James S McCarthy; Michael F Good
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships.

Authors:  Karen M Walker; Shinji Okitsu; David W Porter; Christopher Duncan; Mario Amacker; Gerd Pluschke; David R Cavanagh; Adrian V S Hill; Stephen M Todryk
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

Review 5.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

6.  BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.

Authors:  Anja Scholzen; Anne C Teirlinck; Else M Bijker; Meta Roestenberg; Cornelus C Hermsen; Stephen L Hoffman; Robert W Sauerwein
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

7.  Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.

Authors:  Stefano Colloca; Eleanor Barnes; Antonella Folgori; Virginia Ammendola; Stefania Capone; Agostino Cirillo; Loredana Siani; Mariarosaria Naddeo; Fabiana Grazioli; Maria Luisa Esposito; Maria Ambrosio; Angela Sparacino; Marta Bartiromo; Annalisa Meola; Kira Smith; Ayako Kurioka; Geraldine A O'Hara; Katie J Ewer; Nicholas Anagnostou; Carly Bliss; Adrian V S Hill; Cinzia Traboni; Paul Klenerman; Riccardo Cortese; Alfredo Nicosia
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

8.  Equivalence of ELISpot assays demonstrated between major HIV network laboratories.

Authors:  Dilbinder K Gill; Yunda Huang; Gail L Levine; Anna Sambor; Donald K Carter; Alicia Sato; Jakub Kopycinski; Peter Hayes; Bridget Hahn; Josephine Birungi; Tony Tarragona-Fiol; Hong Wan; Mark Randles; Andrew Raxworthy Cooper; Aloysius Ssemaganda; Lorna Clark; Pontiano Kaleebu; Steven G Self; Richard Koup; Blake Wood; M Juliana McElrath; Josephine H Cox; John Hural; Jill Gilmour
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

9.  Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis.

Authors:  Alessandro S Farias; Rafael L Talaisys; Yara C Blanco; Stefanie C P Lopes; Ana Leda F Longhini; Fernando Pradella; Leonilda M B Santos; Fabio T M Costa
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.

Authors:  Kiprotich Chelimo; Paula B Embury; Peter Odada Sumba; John Vulule; Ayub V Ofulla; Carole Long; James W Kazura; Ann M Moormann
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.